SCHEMBL9997239

SCHEMBL9997239

CCC/C(=C\c1ccccc1CC)C(OC(C)=O)OC(C)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.35
CYP3A4 P08684 6/20 0.35
TSHR P16473 4/20 0.35
ALDH1A1 P00352 3/20 0.35
KMT2A Q03164 2/20 0.34
CYP2C19 P33261 4/20 0.34
CYP2C9 P11712 3/20 0.34
MAPK1 P28482 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP2D6 P10635 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997241 1.00 CYP1A2 (0.35) CYP1A2CYP3A4TSHRALDH1A1KMT2A
SCHEMBL9997548 0.92 KMT2A (0.35) CYP1A2CYP3A4TSHRALDH1A1KMT2A
SCHEMBL9997547 0.92 KMT2A (0.35) CYP1A2CYP3A4TSHRALDH1A1KMT2A
SCHEMBL9997565 0.89 THRA (0.37) CYP3A4ALDH1A1CYP2C9CYP2D6
SCHEMBL9997566 0.89 THRA (0.37) CYP3A4ALDH1A1CYP2C9CYP2D6
SCHEMBL9997860 0.88 KCNH2 (0.34) CYP3A4TSHRALDH1A1KMT2AHDAC3
SCHEMBL9997859 0.88 KCNH2 (0.34) CYP3A4TSHRALDH1A1KMT2AHDAC3
SCHEMBL9997714 0.86 P2RX7 (0.37) CYP1A2CYP3A4TSHRALDH1A1KMT2A
SCHEMBL9997719 0.86 P2RX7 (0.37) CYP1A2CYP3A4TSHRALDH1A1KMT2A
SCHEMBL9998020 0.84 NLRP3 (0.33) CYP1A2CYP3A4TSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP1A2 19/4885CYP3A4 36/4885TSHR 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.